Microbial Colonization Clinical Trial
— GEEFomjebuikOfficial title:
Gut Health Enhancement by Eating Favourable Food
Verified date | September 2023 |
Source | VU University of Amsterdam |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Within the GEEF om je buik study the effect of 8 weeks intervention with either a diet rich in fiber or fermented food on the gut microbiota will be investigated.
Status | Active, not recruiting |
Enrollment | 146 |
Est. completion date | March 5, 2024 |
Est. primary completion date | November 26, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Men and Women, aged =18 - =70 years; - Being able to read and speak Dutch; - Willing to keep a stable dietary pattern throughout the study, apart from the dietary advice in the study; - Having a smartphone compatible with the Lifedata or PocketQ app to fill out the daily questionnaires. Exclusion Criteria: - Having a disease or medical condition which can influence the study results such as diabetes, cancer, diagnosed irritable bowel syndrome, renal disease, liver enzyme abnormality, malignant neoplasm, or a history of inflammatory diseases (such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease); - Having a history of intestinal surgery that might interfere with study outcomes (this does not include an appendectomy or cholecystectomy); - Average dietary fiber intake of =18 gram (women) or =22 gram (men) per day, according to the fiber screen questionnaire (see F1 questionnaires); - More than 3 servings of fermented foods per day as assessed with the fermented food frequency questionnaire (see F1 questionnaires); - Having a Body Mass Index (BMI) of = 30 kg/m2 (self-reported); - Currently following a strict diet and unwilling or unable to change; for example, a gluten free diet or a "crash diet" using meal substitutes; - Specific food allergies that interfere with dietary intervention (for example, gluten, lactose, etc); - Use of prebiotics, probiotics and/or synbiotics (this should be stopped 4 weeks before the start of the study) and use of fiber supplements; - Use of antibiotic treatment less than 3 months before start of the study and/or use of antibiotics during the study; - Use of medication that can interfere with the study outcomes, as judged by the medical supervisor; - Alcoholic use of =14 (women) or =28 (men) glasses of alcoholic beverages per week; - Use of soft or hard drugs (should be stopped at least 4 weeks before start of the study); - Being pregnant or lactating; - Participation in another clinical trial at the same time; - Student or employee working at either Food, Health and Consumer Research from Wageningen Food and Biobased Research, Microbiology at VU, the MLDS, at WholeFiber, Keep Food Simple or at Cidrani; - Unable to follow or comply to study rules. |
Country | Name | City | State |
---|---|---|---|
Netherlands | Stichting Wageningen Research | Wageningen | Gelderland |
Lead Sponsor | Collaborator |
---|---|
VU University of Amsterdam | Cidrani, Keep Food Simple, Maag Lever Darm Stichting, Wageningen University and Research, WholeFiber |
Netherlands,
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. do — View Citation
Myhrstad MCW, Tunsjo H, Charnock C, Telle-Hansen VH. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials. Nutrients. 2020 Mar 23;12(3):859. doi: 10.3390/nu12030859. — View Citation
Stiemsma LT, Nakamura RE, Nguyen JG, Michels KB. Does Consumption of Fermented Foods Modify the Human Gut Microbiota? J Nutr. 2020 Jul 1;150(7):1680-1692. doi: 10.1093/jn/nxaa077. — View Citation
Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, Topf M, Gonzalez CG, Van Treuren W, Han S, Robinson JL, Elias JE, Sonnenburg ED, Gardner CD, Sonnenburg JL. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021 Aug 5;184 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2 | Baseline (week 0) | |
Other | Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2 | End ramp-up (week 2) | |
Other | Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2 | End intervention (week 8) | |
Other | Body Mass Index (BMI) | Weight and height will be combined to report BMI in kg/m^2 | End follow-up (5 months) | |
Primary | Microbiota diversity | Microbioal richness (ASV) using 16s rRNA | Baseline (week 0) | |
Primary | Microbiota diversity | Microbioal richness (ASV) using 16s rRNA | End ramp-up (week 2) | |
Primary | Microbiota diversity | Microbioal richness (ASV) using 16s rRNA | End intervention (week 8) | |
Secondary | Gut microbiota composition | 16s rRNA | Baseline (week 0) | |
Secondary | Gut microbiota composition | 16s rRNA | End ramp-up (week 2) | |
Secondary | Gut microbiota composition | 16s rRNA | End intervention (week 8) | |
Secondary | Carbohydrate Active Enzymes (CAZymes) | Relative abundance of CAZymes using shotgun metagenomic sequencing | Baseline (week 0) | |
Secondary | Carbohydrate Active Enzymes (CAZymes) | Relative abundance of CAZymes using shotgun metagenomic sequencing | End ramp-up (week 2) | |
Secondary | Carbohydrate Active Enzymes (CAZymes) | Relative abundance of CAZymes using shotgun metagenomic sequencing | End intervention (week 8) | |
Secondary | 92 inflammatory serum proteins | 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). | Baseline (week 0) | |
Secondary | 92 inflammatory serum proteins | 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). | End ramp-up (week 2) | |
Secondary | 92 inflammatory serum proteins | 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). | End intervention (week 8) | |
Secondary | Dietary intake | Average intake of fiber, fermented foods and macronutrients using the Traqq app | Baseline (week 0) | |
Secondary | Dietary intake | Average intake of fiber, fermented foods and macronutrients using the Traqq app | End ramp-up (week 2) | |
Secondary | Dietary intake | Average intake of fiber, fermented foods and macronutrients using the Traqq app | End intervention (week 8) | |
Secondary | Dietary intake | Average intake of fiber, fermented foods and macronutrients using the Traqq app | End follow-up (5 months) | |
Secondary | Gastrointestinal complaints | Likert-point scale (scores 0 - 10), for bloating, flatulence and abdominal pain. A higher score means more bloating, flatulence and abdominal pain. | Daily during intervention (week 0 - week 8) | |
Secondary | Stool frequency | Frequency of bowel movement per day | Daily during intervention (week 0 - week 8) | |
Secondary | Stool consistency | Consistency per stool, based on Bristol Stool Score (type 1 -7). Scores 1-7. A higher score means more loose / watery stool. | Daily during intervention (week 0 - week 8) | |
Secondary | Abundance of Prevotella | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | Baseline (week 0) | |
Secondary | Abundance of Prevotella | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End ramp-up (week 2) | |
Secondary | Abundance of Prevotella | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End intervention (week 8) | |
Secondary | Abundance of Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | Baseline (week 0) | |
Secondary | Abundance of Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End ramp-up (week 2) | |
Secondary | Abundance of Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End intervention (week 8) | |
Secondary | Ratio of Prevotella/Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | Baseline (week 0) | |
Secondary | Ratio of Prevotella/Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End ramp-up (week 2) | |
Secondary | Ratio of Prevotella/Bacteroides | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End intervention (week 8) | |
Secondary | Microbial alpha diversity | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | Baseline (week 0) | |
Secondary | Microbial alpha diversity | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End ramp-up (week 2) | |
Secondary | Microbial alpha diversity | Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). | End intervention (week 8) | |
Secondary | Transit time | Using blue dye method (two blue muffins) | Baseline (week 0) | |
Secondary | Transit time | Using blue dye method (two blue muffins) | End ramp-up (week 2) | |
Secondary | Transit time | Using blue dye method (two blue muffins) | End intervention (week 8) | |
Secondary | Sleep quality | Athens insomnia scale. Score range: 0-28 points. Higher score means worse outcome. | Baseline (week 0) | |
Secondary | Sleep quality | Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. | End ramp-up (week 2) | |
Secondary | Sleep quality | Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. | End intervention (week 8) | |
Secondary | Sleep quality | Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. | End follow-up (5 months) | |
Secondary | Digestion associated Quality of Life | Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. | Baseline (week 0) | |
Secondary | Digestion associated Quality of Life | Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. | End ramp-up (week 2) | |
Secondary | Digestion associated Quality of Life | Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. | End intervention (week 8) | |
Secondary | Digestion associated Quality of Life | Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. | End follow-up (5 months) | |
Secondary | Well-being | World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. | Baseline (week 0) | |
Secondary | Well-being | World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. | End ramp-up (week 2) | |
Secondary | Well-being | World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. | End intervention (week 8) | |
Secondary | Well-being | World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. | End follow-up (5 months) | |
Secondary | Subjective health (perception and awareness) | A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health | Baseline (week 0) | |
Secondary | Subjective health (perception and awareness) | A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health | End intervention (week 8) | |
Secondary | Subjective health (perception and awareness) | A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health | End follow-up (5 months) | |
Secondary | Intention to stay healthy (perception + awareness) | A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy | Baseline (week 0) | |
Secondary | Intention to stay healthy (perception + awareness) | A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy | End intervention (week 8) | |
Secondary | Intention to stay healthy (perception + awareness) | A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy | End follow-up (5 months) | |
Secondary | Dietary intrinsic motivation (perception + awareness) | A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. | Baseline (week 0) | |
Secondary | Dietary intrinsic motivation (perception + awareness) | A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. | End intervention (week 8) | |
Secondary | Dietary intrinsic motivation (perception + awareness) | A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. | End follow-up (5 months) | |
Secondary | Dietary self-efficacy (perception + awareness) | A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy | Baseline (week 0) | |
Secondary | Dietary self-efficacy (perception + awareness) | A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy | End intervention (week 8) | |
Secondary | Dietary self-efficacy (perception + awareness) | A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy | End follow-up (5 months) | |
Secondary | Self-regulation (perception + awareness) | A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation | Baseline (week 0) | |
Secondary | Self-regulation (perception + awareness) | A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation | End intervention (week 8) | |
Secondary | Self-regulation (perception + awareness) | A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation | End follow-up (5 months) | |
Secondary | Subjective knowledge (perception + awareness) | A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge | Baseline (week 0) | |
Secondary | Subjective knowledge (perception + awareness) | A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge | End intervention (week 8) | |
Secondary | Subjective knowledge (perception + awareness) | A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge | End follow-up (5 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05414994 -
Assessment of the Ocular Microbiome in Health and Disease
|
||
Completed |
NCT04769882 -
Er:YAG Laser Effects on Microbial Population in Conservative Dentistry
|
N/A | |
Completed |
NCT04766528 -
Effect of Diet on the Microbiota / Endoccanabinoidome Axis in Response to Physical Activity
|
N/A | |
Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
Completed |
NCT04122612 -
Shaping Microbiome in the First 1,000 Days of Life
|
||
Not yet recruiting |
NCT05405634 -
Microbiota in Chronic Anal Fissure and Its Association With Prognosis
|
||
Not yet recruiting |
NCT04895774 -
Ex Vivo Study of the Mechanism of Action of Active Ingredients on the Intestinal Microbiota
|
||
Recruiting |
NCT05992688 -
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
|
N/A | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Completed |
NCT05175833 -
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19
|
Phase 2 | |
Recruiting |
NCT04836910 -
Microbiome and Polycystic Ovaries
|
||
Recruiting |
NCT05603650 -
Effects of Mouthrinses on the Microbiome of the Oral Cavity and GI Tract
|
N/A | |
Completed |
NCT04991818 -
MSC - OneBiome UX Pilot Study
|
N/A | |
Completed |
NCT05575050 -
Impact of Teeth Brushing in Ventilated COVID-19 Patients.
|
N/A | |
Completed |
NCT04374955 -
The Effect of Probiotic Added to Maternal Diet on Infantile Colic and Intestinal Microbiota Content
|
N/A | |
Recruiting |
NCT04140747 -
Transfer of Strictly Anaerobe Microbes From Mother to Child
|
||
Recruiting |
NCT04111471 -
The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients
|
N/A | |
Suspended |
NCT03220282 -
The Milk, Growth and Microbiota Study
|
N/A | |
Completed |
NCT03422562 -
Probiotics and Intestinal Microbiome in Preterm Infants
|
Phase 3 | |
Recruiting |
NCT05695196 -
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
|
Phase 1 |